US Stock MarketDetailed Quotes

ALDX Aldeyra Therapeutics

Watchlist
  • 4.900
  • -0.110-2.20%
Close Dec 13 16:00 ET
  • 4.880
  • -0.020-0.41%
Post 20:02 ET
291.79MMarket Cap-6.53P/E (TTM)

Aldeyra Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
0.62%-7.97M
1.00%-13.22M
-5.60%-9.97M
46.46%-30.33M
104.46%500.44K
36.18%-8.02M
33.07%-13.36M
26.64%-9.44M
-33.09%-56.64M
2.99%-11.23M
Net income from continuing operations
-84.60%-15.11M
-87.47%-16.85M
48.24%-8.08M
39.47%-37.54M
63.16%-4.75M
43.75%-8.19M
49.46%-8.99M
6.98%-15.62M
-7.35%-62.02M
18.11%-12.9M
Depreciation and amortization
-3.10%62.99K
-4.21%61.63K
-9.47%60.63K
1.57%262.78K
-0.26%66.47K
-0.48%65K
0.51%64.34K
6.74%66.97K
-2.07%258.71K
8.77%66.64K
Other non cash items
-60.78%37.63K
-62.50%37.63K
-33.28%58.15K
6.96%354.19K
-14.51%70.75K
15.87%95.94K
21.19%100.34K
5.27%87.16K
-19.13%331.15K
-0.06%82.75K
Change In working capital
648.12%4.32M
134.60%2.11M
-283.85%-3.39M
125.00%861.18K
562.65%5.92M
-103.09%-788.2K
-69.07%-6.11M
0.31%1.84M
-146.30%-3.44M
-141.95%-1.28M
-Change in prepaid assets
1,974.10%1.34M
405.82%2.49M
-175.57%-2.82M
146.14%1.73M
56.70%-1.11M
29.40%-71.57K
-156.70%-814.44K
247.73%3.73M
-267.94%-3.76M
-205.20%-2.57M
-Change in payables and accrued expense
515.70%2.98M
92.88%-377.02K
70.12%-565.05K
-2,273.11%-6.87M
-20.23%1.03M
-149.93%-716.63K
-4.85%-5.29M
-143.35%-1.89M
-93.92%316.31K
112.53%1.29M
-Change in other working capital
----
----
----
--6M
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
0.62%-7.97M
1.00%-13.22M
-5.60%-9.97M
46.46%-30.33M
104.46%500.44K
36.18%-8.02M
33.07%-13.36M
26.64%-9.44M
-33.09%-56.64M
2.99%-11.23M
Investing cash flow
Cash flow from continuing investing activities
5.26M
-18.24M
-201.26%-30.38M
200.15%30M
0
0
0
151.70%30M
-383,637.25%-29.95M
27M
Net PPE purchase and sale
----
----
----
--0
----
----
----
----
-109.03%-16.32K
--0
Net investment purchase and sale
--5.26M
---18.24M
-201.26%-30.38M
200.21%30M
--0
--0
--0
151.71%30M
---29.94M
--27M
Cash from discontinued investing activities
Investing cash flow
--5.26M
---18.24M
-201.26%-30.38M
200.15%30M
--0
--0
--0
151.70%30M
-383,637.25%-29.95M
--27M
Financing cash flow
Cash flow from continuing financing activities
37.49%-197.39K
0
-65.39%18.19K
-204.11%-1.27M
-1.01M
-126.38%-315.76K
5.29K
125.34%52.56K
-99.37%1.22M
0
Proceeds from stock option exercised by employees
-90.85%19.87K
--0
-65.39%18.19K
-74.98%305.23K
--30.19K
-81.85%217.19K
--5.29K
125.34%52.56K
-73.96%1.22M
--0
Net other financing activities
----
----
----
---1.58M
---1.04M
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
37.49%-197.39K
--0
-65.39%18.19K
-204.11%-1.27M
---1.01M
-126.38%-315.76K
--5.29K
125.34%52.56K
-99.37%1.22M
--0
Net cash flow
Beginning cash position
-53.17%71.03M
-37.89%102.49M
-1.11%142.82M
-37.15%144.42M
11.41%143.33M
25.34%151.68M
3.85%165.03M
-37.15%144.42M
195.14%229.79M
-46.70%128.65M
Current changes in cash
65.11%-2.91M
-135.63%-31.46M
-295.70%-40.33M
98.13%-1.6M
-103.25%-511.87K
-209.19%-8.34M
64.77%-13.35M
129.07%20.61M
-156.19%-85.37M
236.20%15.77M
End cash Position
-52.47%68.12M
-53.17%71.03M
-37.89%102.49M
-1.11%142.82M
-1.11%142.82M
11.41%143.33M
25.34%151.68M
3.85%165.03M
-37.15%144.42M
-37.15%144.42M
Free cash flow
0.62%-7.97M
1.00%-13.22M
-5.60%-9.97M
46.47%-30.33M
104.46%500.44K
36.18%-8.02M
33.07%-13.36M
26.73%-9.44M
-33.10%-56.65M
2.99%-11.23M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 0.62%-7.97M1.00%-13.22M-5.60%-9.97M46.46%-30.33M104.46%500.44K36.18%-8.02M33.07%-13.36M26.64%-9.44M-33.09%-56.64M2.99%-11.23M
Net income from continuing operations -84.60%-15.11M-87.47%-16.85M48.24%-8.08M39.47%-37.54M63.16%-4.75M43.75%-8.19M49.46%-8.99M6.98%-15.62M-7.35%-62.02M18.11%-12.9M
Depreciation and amortization -3.10%62.99K-4.21%61.63K-9.47%60.63K1.57%262.78K-0.26%66.47K-0.48%65K0.51%64.34K6.74%66.97K-2.07%258.71K8.77%66.64K
Other non cash items -60.78%37.63K-62.50%37.63K-33.28%58.15K6.96%354.19K-14.51%70.75K15.87%95.94K21.19%100.34K5.27%87.16K-19.13%331.15K-0.06%82.75K
Change In working capital 648.12%4.32M134.60%2.11M-283.85%-3.39M125.00%861.18K562.65%5.92M-103.09%-788.2K-69.07%-6.11M0.31%1.84M-146.30%-3.44M-141.95%-1.28M
-Change in prepaid assets 1,974.10%1.34M405.82%2.49M-175.57%-2.82M146.14%1.73M56.70%-1.11M29.40%-71.57K-156.70%-814.44K247.73%3.73M-267.94%-3.76M-205.20%-2.57M
-Change in payables and accrued expense 515.70%2.98M92.88%-377.02K70.12%-565.05K-2,273.11%-6.87M-20.23%1.03M-149.93%-716.63K-4.85%-5.29M-143.35%-1.89M-93.92%316.31K112.53%1.29M
-Change in other working capital --------------6M------------------------
Cash from discontinued investing activities
Operating cash flow 0.62%-7.97M1.00%-13.22M-5.60%-9.97M46.46%-30.33M104.46%500.44K36.18%-8.02M33.07%-13.36M26.64%-9.44M-33.09%-56.64M2.99%-11.23M
Investing cash flow
Cash flow from continuing investing activities 5.26M-18.24M-201.26%-30.38M200.15%30M000151.70%30M-383,637.25%-29.95M27M
Net PPE purchase and sale --------------0-----------------109.03%-16.32K--0
Net investment purchase and sale --5.26M---18.24M-201.26%-30.38M200.21%30M--0--0--0151.71%30M---29.94M--27M
Cash from discontinued investing activities
Investing cash flow --5.26M---18.24M-201.26%-30.38M200.15%30M--0--0--0151.70%30M-383,637.25%-29.95M--27M
Financing cash flow
Cash flow from continuing financing activities 37.49%-197.39K0-65.39%18.19K-204.11%-1.27M-1.01M-126.38%-315.76K5.29K125.34%52.56K-99.37%1.22M0
Proceeds from stock option exercised by employees -90.85%19.87K--0-65.39%18.19K-74.98%305.23K--30.19K-81.85%217.19K--5.29K125.34%52.56K-73.96%1.22M--0
Net other financing activities ---------------1.58M---1.04M--------------------
Cash from discontinued financing activities
Financing cash flow 37.49%-197.39K--0-65.39%18.19K-204.11%-1.27M---1.01M-126.38%-315.76K--5.29K125.34%52.56K-99.37%1.22M--0
Net cash flow
Beginning cash position -53.17%71.03M-37.89%102.49M-1.11%142.82M-37.15%144.42M11.41%143.33M25.34%151.68M3.85%165.03M-37.15%144.42M195.14%229.79M-46.70%128.65M
Current changes in cash 65.11%-2.91M-135.63%-31.46M-295.70%-40.33M98.13%-1.6M-103.25%-511.87K-209.19%-8.34M64.77%-13.35M129.07%20.61M-156.19%-85.37M236.20%15.77M
End cash Position -52.47%68.12M-53.17%71.03M-37.89%102.49M-1.11%142.82M-1.11%142.82M11.41%143.33M25.34%151.68M3.85%165.03M-37.15%144.42M-37.15%144.42M
Free cash flow 0.62%-7.97M1.00%-13.22M-5.60%-9.97M46.47%-30.33M104.46%500.44K36.18%-8.02M33.07%-13.36M26.73%-9.44M-33.10%-56.65M2.99%-11.23M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data